Clinical trial
Comparing the Efficacy of a Periarticular Instillation of Extended Relief Bupivacaine and Meloxicam With Routine Adductor Canal Blockade for Pain Relief After Primary TKA
NCT05751421 is registered in ClinicalTrials.gov with Rothman Institute Orthopaedics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparing the Efficacy of a Periarticular Instillation of Extended Relief Bupivacaine and Meloxicam With Routine Adductor Canal Blockade for Pain Relief After Primary TKA
- Lead sponsor
- Rothman Institute Orthopaedics
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- February 28, 2023
- Completion date
- February 28, 2024
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pain, postoperative